Poster Exhibition

Presentation type	Presentation day	Track	Poster Group	Text
All Oral abstracts Poster Discussions Poster Exhibition CD-ROM	All Sunday, 3 August 2008 Monday, 4 August 2008 Tuesday, 5 August 2008 Wednesday, 6 August 2008 Thursday, 7 August 2008 Friday, 8 August 2008	All A B C D E	All Abstinence, monogamy and sexual fidelity Access and availability of HIV/AIDS treatment and care, health services and mental health Access to and models of care Access to information, transparency and accountability Access to therapy and strategies and models of delivery Acute early infection including infectivity Adaptation to living with HIV for individuals, families and communities Adherence Advocacy and lobbying by civil society, affected communities and PLWHAs Aging with HIV AIDS development and the Millennium Goals AIDS related malignancies (KS, lymphoma, cervical and anal carcinoma) including HHV8 infection Analysis of resource allocation and monitoring of their use Animal and cellular models of HIV pathogenesis Animal models for vaccine development Antiretroviral resistance surveillance Antiretroviral therapy of pregnant women Basic immunology of clinical vaccines Behavioral surveillance Bioinformatics Blood, organ and tissue safety Capacity building for HIV prevention research Capacity building for leadership and advocacy Clinical trials - phase I/II Clinical trials - phase III/post-licensing Clinical trials and antiretroviral therapy Collective and individual sexual rights Community participation in research Compartmentalization Complementary and traditional medicines and the role of traditional healers in therapy Concepts of immune based therapy Conflict and post-conflict situations Cross-national comparisons Cultural issues in care and therapy Cultural understandings of illness and caring Determinants of HIV risk and protective behaviors Development and poverty alleviation Diagnosis, and disclosure of HIV disease Disasters and HIV Discrimination, stigma and social exclusion Discrimination, stigma, social exclusion and criminalisation Disease burden - morbidity/mortality Disorders of immune reconstitution Drug and alcohol use, social exclusion, social supports and other psycho-social issues Economic and human development dimensions of the epidemic Economic evaluation of prevention, care and mitigation programmes (including cost effectiveness) Economic strengthening initiatives (including micro-finance, health insurance, etc.) Education and child welfare Effects of homophobia Efficiency and equity in access to treatment and prevention Entry inhibitors Epidemiology of HIV-1 and HIV-2 subtypes spreading Epidemiology of sexual behaviour Epidemiology of sexually transmitted infections (STI) and HIV Epidemiology of tuberculosis and HIV Epidemiology of viral hepatitis and HIV co-infection Epidemiology of vulnerabilities to HIV Ethical issues in prevention research Ethics (including research, clinical, public health and professional ethics) Ethics and priority setting and resource allocation Ethnographic methods in HIV/AIDS research Evaluation of ARV delivery outcome in resource constrained settings Evaluation of behavioral interventions for people living with HIV Evidence-based advocacy on budget and policy priorities Evidence-based policy development Evidence-based research as a method of policy change Family, orphans and other vulnerable children and their care-givers Financial sustainability of the response to HIV/AIDS Gender inequalities, partners and relationships Gene therapy Genotyping and phenotyping Globalization and its effects, including structural adjustment and health sector reform Globalization of health services and movement of health workers Growing up with HIV/AIDS: early infection, children and youth Harm reduction, including reduction of unsafe injecting and other harm reduction approaches Harm-reduction strategies and HIV prevention programmes for drug users Hepatitis co-infections: (including HBV, HCV) Histories of policy responses to the epidemic HIV counseling and testing HIV diversity and response to ARV HIV reservoirs HIV seroepidemiologic studies HIV/AIDS and the workplace, unemployment, return to work and rehabilitation HIV-specific cellular immunity HIV-specific humoral immunity HIV-specific mucosal immunity Home care/ nursing and holistic care Host genetic and HIV evolution Host genetic factors of pathogenesis Human and food security Human resources and health systems Immune reconstitution Impact and level of Integration of HIV care with other health care delivery systems Impact of co-factors/viral clade/tropism/genetic factors Impact of donor agencies and policies on national responses Impact of policies on health systems Incarcerated populations Indigenous people and HIV Individual level interventions Influencing policy development and policies Innate immunity Integrase inhibitors Integrating HIV prevention and care and treatment programmes Integrating HIV prevention into reproductive health/STI programmes Integrating prevention into treatment and care services Integration of HIV prevention programmes and other health programmes International assistance and funding mechanisms International trade law and intellectual property Interventions addressing vulnerabilities to HIV and AIDS Interventions at the group, community, institutional or structural levels Interventions to prevent mother-to-child transmission Intracellular restriction of HIV replication Involvement of PLWHA and other affected people in the research process Laboratory monitoring of immune reconstitution Law enforcement and criminal justice Legal issues, laws and law reform Lipodystrophy, metabolic abnormalities, cardiovascular disease Living with ART: impact, quality of life, body change and sexual behavior Living with co-infections: TB and HIV, HCV, HPV and HIV Male and female condoms and other physical barriers Male circumcision Maturation and assembly Measuring new HIV infections Mechanisms of drug resistance Mechanisms of immune dysfunction Media and cultural representations Methods for measuring vulnerability and social inequality Methods in social epidemiology Microbicides Migrants, refugees and mobile populations Mobile and immigrant populations (including people living with HIV) Modeling Molecular epidemiology of HIV diversity Monitoring and evaluation Monitoring and evaluation of policies and their impact on PLWHA, affected communities and vulnerable populations Multi-sectoral policy development Mycobacterial (including TB and MAC) infections National and local government financing Natural history, progression and survival Neurologic and psychiatric manifestations New laboratory monitoring strategies including rapid tests Non- epidemiological aspects of sexually transmitted infections (STI), including HPV and syphilis Non-AIDS related malignancies, morbidities and ageing Non-heterosexual populations Non-nucleosides Novel research designs in epidemiology Novel research designs in prevention research Nucleosides and nucleotides Nutrition Nutrition, infant feeding and poverty (including people living with HIV) Opportunistic infections (excluding TB) Opportunistic infections surveillance Other adverse reactions and complications of ARV therapy Other bacterial infections and malaria and parasitic infections Other human and animal retroviruses Other targets Palliative care/terminal care Pharmacoeconomics and cost effectiveness of care and treatment Pharmacology, pharmacokinetics, drug formulations Pharmacology, pharmacokinetics, role of therapeutic drug monitoring, drug interactions Policies addressing HIV/AIDS in the workplace and educational institutions Policies addressing social and economic determinants of vulnerability Policies of sexual regulation Policies regarding HIV prevention, diagnosis, treatment and care Policy analysis and indicators of policy effectiveness Policy determinants and constraints Population-based surveys with HIV testing Post-exposure prophylaxis Preclinical development of HIV vaccines Preclinical development of microbicides Pre-exposure prophylaxis Prevention among adolescents and youth Prevention programmes addressing gender inequalities Prevention programmes for immigrants, mobile and displaced populations Prevention programmes for indigenous populations Prevention programmes for male and female sex workers Prevention programmes for men who have sex with men (MSM) Prevention programmes for people living with HIV Prevention programmes for the general population Prevention programmes for transgenders Prevention programmes for youth and adolescents Prevention programmes in institutional settings e.g. workplace, school, prison, military Prevention programmes to reduce HIV infections in infants Primary care and health maintenance Primary infection Primary infection and management of patients with acquired viral resistance Prognostic staging of disease Prophylaxis of HIV associated infections; vaccines e.g. pneumococcal, hepatitis and HPV, co-trimoxazole prophylaxis and IPT Protease inhibitors Protection, empowerment and involvement of PLWHAs and vulnerable populations Provision of care, diagnosis and treatment for HIV exposed Provision of HIV related care and therapy in difficult to treat populations Provision of HIV related care and therapy, maintenance/substitution therapy and adherence in injection (IDUs) and other drug users Psychological well being and mental health Race, racism and ethnicity Religious institutions and faith communities Reproductive health, fertility, sexuality and HIV prevention strategies Reverse transcription Risk and harm reduction Risk behaviour, quality of life and access to care in harm reduction approaches Risk factors for acquisition of HIV Risk factors for infectivity, susceptibility, progression and transmission of HIV Role of media in policy making Role of military and police Role of multilateral agencies and donors Roles and responsibilities of PLWHAs and vulnerable populations Roles and responsibilities of state, civil society and the private sector Roles and responsibilities of the state, civil society and private and business sectors Second line, third line and therapy for the heavily pre-treated patient Seropositivity: social identity, disclosure and vulnerability Sex work and other forms of transactional sex Sexual and reproductive health and fertility: considerations and rights Sexual meanings, identities and communities Simplification strategies (induction/maintenance and use of bPI monotherapy) Social and behavioural change theories, limits and possibilities Social and cultural factors influencing HIV vulnerability and prevention Social class, poverty and socioeconomic stratification Social welfare Social, psychological and behavioural aspects of HIV testing, counselling and prevention Socio-historical analyses of HIV/AIDS: the third decade Special care issues for women Specific issues in prevention, treatment and care for women and girls STI prevention and control Surveillance of HIV and AIDS Surveillance systems and methods Sustainability and availability of interventions Sustainability of ART programmes and adherence in developing countries Sustainability of financing The impact of ideology, religion and culture on policy The relationship between human rights and HIV/AIDS The role of nurses and other health care professionals in delivery of care Therapeutic vaccine and immune based therapy trials Trade, patents and pharmaceutical production and availability Transgender and intersexual people Treatment interruptions and CD4 guided therapy Trends in morbidity and mortality Understanding and measuring adherence/compliance Vaccines Violence: gender, social, structural and family-based Viral and host factors in long-term non progressors Viral dynamics and fitness Viral entry and tropism Viral fitness and tropism assays, utility and application in clinical practice Viral regulatory genes Viral resistance testing in clinical trials and practice Vulnerability reduction When to start therapy, first line regimens, management of late presenters When to switch therapy Young people and sexuality